Dianna Gaballa

Dianna Gaballa practices at White Plains Hospital in White Plains, New York, part of Montefiore Einstein.

Dianna Gaballa's NPI, 1932638616, was assigned on June 7, 2017. Dianna Gaballa holds Pennsylvania license MT213434.

Dianna Gaballa's primary practice is White Plains Hospital, at Davis Ave at E Post Road, White Plains, NY 10601 in Westchester County. The practice phone is (914) 681-0600. Dianna Gaballa also practices at White Plains Hospital, 41 E Post Rd, White Plains, NY 10601.

Dianna Gaballa's primary practice is White Plains Hospital in White Plains, New York, part of Montefiore Einstein. Dianna Gaballa is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Highland Medical Group. Dmand AI also links Dianna Gaballa to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dianna Gaballa practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dianna Gaballa's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dianna Gaballa is licensed in Pennsylvania.

CMS data shows 473 Medicare services from Dianna Gaballa across 10 procedure codes in 2024, for 258 Medicare patients. Medicare paid $30,144 for them.

CMS counts 258 Medicare patients who saw Dianna Gaballa in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dianna Gaballa's median patient age at 65, with 57% women.

In 2024, Dianna Gaballa wrote 227 Medicare Part D claims for 78 patients. 91% of them were for generic drugs. CMS names the drug for 117 of them, across 5 drugs with 11 or more claims each, at $1,325 in total drug cost. In 2023, CMS named 85 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dianna Gaballa for performance year 2024, reported as part of a group. Dianna Gaballa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dianna Gaballa as offering telehealth.

CMS Open Payments shows 129 general payments to Dianna Gaballa from 22 drug and device companies from 2020 to 2025. Grants make up the largest share, 84% of the total. AstraZeneca Pharmaceuticals LP paid the most, $20,999.